Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Clin Gastroenterol. 2019 Jul;53(6):e232–e238. doi: 10.1097/MCG.0000000000001063

Table 4.

Treatments Utilized in Children with ARP or CP by PD Status

Pancreas
Divisum=Yes
(n=52)
Pancreas
Divisum=No (n=307)
p-value

Medical Therapies
  Pain medications 20/49 (41%) 121/274 (44%) 0.66
  Pancreatic enzymes 20/50 (40%) 105/273 (38%) 0.83
  Vitamins/antioxidants 17/50 (34%) 118/276 (43%) 0.24
  Steroids 0/50 (0%) 8/276 (3%) 0.61
  Diabetic medications 3/50 (6%) 22/277 (8%) 0.77

Endoscopic Therapies
  Any ERCP 31/50 (62%) 152/305 (50%) 0.11
  Biliary sphincterotomy 2/49 (4%) 66/299 (22%) <0.01
  Pancreatic sphincterotomy 27/50 (54%) 83/298 (28%) <0.001
  Pancreatic duct stent placement 17/50 (34%) 80/301 (27%) 0.27
  Biliary stent placement 1/50 (2%) 17/301 (6%) 0.48
  Pancreatic duct stone removal 6/50 (12%) 47/300 (16%) 0.50

Surgical Therapies
  Any Pertinent Surgeries 12 (23%) 81/305 (27%) 0.59
  Cholecystectomy 4 (8%) 41/304 (13%) 0.24
  Celiac nerve block 1 (2%) 5/304 (2%) 1.0
  Cyst/pseudo-cyst operation 1 (2%) 13/304 (4%) 0.70
  Lateral pancreaticojejonstomy 2 (4%) 14/304 (4%) 1.0
  Partial pancreatectomy 0 (0%) 2/304 (1%) 1.0
  TPIAT 5 (10%) 34/304 (11%) 1.0

ARP: Acute Recurrent Pancreatitis; CP: Chronic Pancreatitis; PD, pancreas divisum; PERT, pancreatic enzyme replacement therapy; ERCP, endoscopic retrograde cholangiopancreatography; TPIAT, total pancreatectomy with islet auto-transplantation

Significant p values are highlighted